“…These 5-HT enhancing effects of TSD and LT could also explain the sleep reduction in responders, a phenomenon observed in the present study, because pharmacogenetic studies have showed that human homozygotes for the long variants of the serotonin promoter gene polymorphism, which respond better to both antidepressant TSD and serotonergic drugs (Benedetti et al, 1999), also reduce their sleep and increase their nighttime locomotor activity when treated with SSRIs (Putzhammer et al, 2005). Moreover, the DA-enhancing effects of TSD could contribute to the observed effects, because DA can entrain the activity-rest rhythm (Fertl et al, 1993;Honma & Honma, 1995), regulate the generation of sleep-wake states (Dzirasa et al, 2007), and exert complex effects on the physiological functions of sleep and dream mentation (Dahan et al, 2006). Other neurobiological mechanisms could involve the arousal-enhancing transmitter norepinephrine, which is markedly enhanced by TSD (Conti et al, 2007), or the expression of several immediate-early genes and transcription factors, genes related to energy metabolism, growth factors, adhesion molecules, chaperones, and heat shock proteins, vesicle-and synapserelated genes, neurotransmitter and hormone receptors, neurotransmitter transporters, and enzymes, which are enhanced by TSD (Cirelli & Tononi, 2000).…”